当前位置:首页 - 行情中心 - 宣泰医药(688247) - 财务分析 - 现金流量表

宣泰医药

(688247)

  

流通市值:43.02亿  总市值:43.02亿
流通股本:4.53亿   总股本:4.53亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金119,281,470.42503,656,812.62373,652,298.04254,341,100.23
  收到的税费返还187,542.18,246,043.055,433,086.35,433,086.3
  收到其他与经营活动有关的现金2,043,594.3413,485,315.356,636,359.262,774,751.24
  经营活动现金流入小计121,512,606.86525,388,171.02385,721,743.6262,548,937.77
  购买商品、接受劳务支付的现金41,393,452.64239,801,571.84165,502,403.68112,001,973.7
  支付给职工以及为职工支付的现金26,231,261.12104,696,238.8883,495,887.9760,081,014.1
  支付的各项税费4,707,657.728,254,774.1926,429,350.3222,166,189.72
  支付其他与经营活动有关的现金9,002,876.7157,309,727.832,853,322.5619,319,449.73
  经营活动现金流出小计81,335,248.17430,062,312.71308,280,964.53213,568,627.25
  经营活动产生的现金流量净额40,177,358.6995,325,858.3177,440,779.0748,980,310.52
二、投资活动产生的现金流量:
  收回投资收到的现金165,000,0001,962,000,0001,498,000,000945,800,000
  取得投资收益收到的现金1,248,724.659,636,920.897,141,803.214,197,837.74
  投资活动现金流入小计166,248,724.651,971,636,920.891,505,141,803.21949,997,837.74
  购建固定资产、无形资产和其他长期资产支付的现金7,349,996.3941,558,417.0932,313,415.2625,756,866.55
  投资支付的现金460,000,0001,813,100,0001,507,100,000971,100,000
  投资活动现金流出小计467,349,996.391,854,658,417.091,539,413,415.26996,856,866.55
  投资活动产生的现金流量净额-301,101,271.74116,978,503.8-34,271,612.05-46,859,028.81
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金-27,838,140.0318,374,090.7218,374,090.72
  支付其他与筹资活动有关的现金16,840.868,298.868,298.851,083.76
  筹资活动现金流出小计16,840.827,906,438.8318,442,389.5218,425,174.48
  筹资活动产生的现金流量净额-16,840.8-27,906,438.83-18,442,389.52-18,425,174.48
四、汇率变动对现金及现金等价物的影响-2,069,984.25-3,294,230.88-1,412,439.12-431,027.64
五、现金及现金等价物净增加额-263,010,738.1181,103,692.423,314,338.38-16,734,920.41
  加:期初现金及现金等价物余额406,889,473.83225,785,781.43225,785,781.43225,785,781.43
  期末现金及现金等价物余额143,878,735.73406,889,473.83249,100,119.81209,050,861.02
补充资料:
  净利润-47,482,814.69-45,585,665.46
  资产减值准备-17,539,733.26-1,014,367.59
  固定资产和投资性房地产折旧-25,102,090.17-11,082,567.18
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-25,102,090.17-11,082,567.18
  无形资产摊销-6,729,811.12-3,385,877.77
  长期待摊费用摊销-494,046.58-274,020.29
  固定资产报废损失-363,521.15--
  公允价值变动损失--1,341,275.35--
  财务费用-3,274,781.43-334,006.56
  投资损失--9,294,077.87--6,662,038.67
  递延所得税-173,175.03-498,013.92
  其中:递延所得税资产减少-318,487.85-569,811.79
    递延所得税负债增加--145,312.82--71,797.87
  存货的减少-14,434,028.17-896,176.65
  经营性应收项目的减少-22,885,324.76-27,750,904.8
  经营性应付项目的增加--17,747,726.24--26,412,014.21
  其他--16,290,725.38--7,105,091.64
  现金的期末余额-406,889,473.83-209,050,861.02
  减:现金的期初余额-225,785,781.43-225,785,781.43
  现金及现金等价物的净增加额-181,103,692.4--16,734,920.41
公告日期2026-04-302026-04-302025-10-312025-08-23
审计意见(境内)标准无保留意见
TOP↑